CoChat

Significance of serum and hepatic micro RNA‐122 levels in patients with non‐alcoholic fatty liver disease

Miyaaki, Hisamitsu, Ichikawa, Tatsuki, Kamo, Yasuhiro, Taura, Naota, Honda, Takuya, Shibata, Hidetaka, Milazzo, Maddalena, Fornari, Francesca, Gramantieri, Laura, Bolondi, Luigi, Nakao, Kazuhiko · 2014 · Liver International
Cited by 147

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background & Aims: Non‐alcoholic fatty liver disease (NAFLD) is believed to be a type of metabolic syndrome. Micro RNA‐122 (miR‐122) is the most abundant micro RNA in the liver and is an important factor for the metabolism of glucose and lipids. In the present study, we examined the correlation between the hepatic and serum miR‐122 expression levels and the clinicopathological factors of patients with NAFLD. Methods: We extracted the total RNA, along with preserved mi RNA s, from liver biopsy samples of 67 patients with NAFLD. In 52 of these 67 patients, the total RNA was extracted from serum. The miR‐122 that was obtained by quantitative reverse transcription‐polymerase chain reaction was quantified using TaqMan Micro RNA assays. Results: A significant correlation was detected between serum and hepatic miR‐122 expression (correlation coefficient, 0.461; P = 0.005). Patients with mild steatosis (<33%) showed significantly lower levels of hepatic miR‐122 compared with patients with severe steatosis (>33%) (hepatic miR‐122: mild/severe = 2.158 ± 1.786/4.836 ± 7.506, P = 0.0473; serum miR‐122: mild/severe = 0.002 ± 0.005/0.007 ± 0.001, P = 0.0491). Moreover, hepatic and serum miR‐122 levels were significantly higher in patients with mild fibrosis than in those with severe fibrosis (hepatic miR‐122: mild/severe = 5.201 ± 7.275/2.394 ± 1.547, P = 0.0087; serum miR‐122: mild/severe = 0.008 ± 0.011/0.002 ± 0.004, P = 0.0191). Conclusions: We found that the hepatic and serum miR‐122 levels were associated with hepatic steatosis and fibrosis. The serum miR‐122 level can be a useful predictive marker of liver fibrosis in patients with NAFLD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.12429

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 147

Metadata

Authors
Miyaaki, H., Ichikawa, T., Kamo, Y., Taura, N., Honda, T., Shibata, H., Milazzo, M., Fornari, F., Gramantieri, L., Bolondi, L., & Nakao, K.
Venue
Liver International
Publisher
Wiley
Published
2014-01-07
Volume
34
Issue
7
Pages
e302-7
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2134896806
Cited by
147
References
6
FWCI
8.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Significance of serum and hepatic micro RNA‐122 levels in patients with non‐alcoholic fatty liver disease. https://app.cochat.ai/papers/10.1111/liv.12429
The paper
Miyaaki, H., Ichikawa, T., Kamo, Y., Taura, N., Honda, T., Shibata, H., Milazzo, M., Fornari, F., Gramantieri, L., Bolondi, L., & Nakao, K. (2014). Significance of serum and hepatic micro RNA‐122 levels in patients with non‐alcoholic fatty liver disease. Liver International. https://doi.org/10.1111/liv.12429

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.